Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Maintenance Pembrolizumab vs Placebo after First-line Chemo in Pts w/ Metastatic Urothelial Cancer

Protocol: OSU-16133

Full Title

A Randomized, Double-Blinded, Phase II Study of Maintenance Pembrolizumab versus Placebo after First-line Chemotherapy in Patients with Metastatic Urothelial Cancer

Bladder Cancer Genitourinary Cancers